Literature DB >> 16500036

Adipocyte: a potential target for the treatment of atherosclerosis.

Zhi-hong Wu1, Shui-ping Zhao.   

Abstract

Obesity is an independent risk factor for coronary heart disease, whereas the underlying mechanisms have not been fully elucidated. Adipocytes may produce various adipokines with favorable and unfavorable cardiovascular effects. The dysregulated secretion of adipokines by adipocytes may contribute to obese associated atherosclerosis. Adipocytes can also function as phagocytes to uptake and degrade oxidized low-density lipoprotein (Ox-LDL), suggesting that adipocytes possibly involve in clearance of Ox-LDL in blood. The dysfunctional adipocytes might be implicated in the atherogenesis. Some cardioprotective drugs mediate their cardiovascular benefits partly through their direct beneficial effects on adipocytes. Therefore, we hypothesized that adipocytes might be potential target for the treatment of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500036     DOI: 10.1016/j.mehy.2005.12.042

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  9 in total

1.  The change of serum leptin and its relationship with platelet membrane glycoprotein Ib in patients with coronary heart disease.

Authors:  Dasheng Xia; Yanqiu Song; Chao Li; Feng Zhang; Minxin Wei
Journal:  Front Med China       Date:  2007-10

2.  Effects of homocysteine on adipocyte differentiation and CD36 gene expression in 3T3-L1 adipocytes.

Authors:  Ahmet Mentese; Ahmet Alver; Aysegul Sumer; Selim Demir
Journal:  J Cell Commun Signal       Date:  2015-12-21       Impact factor: 5.782

3.  In vitro study of the effect of diesterified alkoxyglycerols with conjugated linoleic acid on adipocyte inflammatory mediators.

Authors:  Aurelio Ocaña; Cristina Gómez-Asensio; Elena Arranz-Gutiérrez; Carlos Torres; Francisco Javier Señoráns; Guillermo Reglero
Journal:  Lipids Health Dis       Date:  2010-04-06       Impact factor: 3.876

4.  Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases.

Authors:  Beatrice Scazzocchio; Rosaria Varì; Massimo D'Archivio; Carmela Santangelo; Carmelina Filesi; Claudio Giovannini; Roberta Masella
Journal:  J Lipid Res       Date:  2009-01-09       Impact factor: 5.922

5.  17β-estradiol lowers triglycerides in adipocytes via estrogen receptor α and it may be attenuated by inflammation.

Authors:  Fei Luo; Wen-Yu Huang; Yuan Guo; Gui-Yun Ruan; Ran Peng; Xiang-Ping Li
Journal:  Lipids Health Dis       Date:  2017-09-25       Impact factor: 3.876

Review 6.  Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases.

Authors:  Jelena Milic; Yuan Tian; Jürgen Bernhagen
Journal:  Biomolecules       Date:  2019-06-05

7.  Identification of key genes and pathways affected in epicardial adipose tissue from patients with coronary artery disease by integrated bioinformatics analysis.

Authors:  Liao Tan; Qian Xu; Qianchen Wang; Ruizheng Shi; Guogang Zhang
Journal:  PeerJ       Date:  2020-03-25       Impact factor: 2.984

8.  Ghrelin Does not Alter Aortic Intima-Media Thickness and Adipose Tissue Characteristics in Control and Obese Mice.

Authors:  Zoya Tahergorabi; Bahman Rashidi; Majid Khazaei
Journal:  Iran J Basic Med Sci       Date:  2013-08       Impact factor: 2.699

9.  Atorvastatin antagonizes the visfatin-induced expression of inflammatory mediators via the upregulation of NF-κB activation in HCAECs.

Authors:  Kai-Lei Shi; Ju-Ying Qian; Lin Qi; Ding-Biao Mao; Yang Chen; Yi Zhu; Xin-Gui Guo
Journal:  Oncol Lett       Date:  2016-06-28       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.